Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REPLIGEN CORP Director's Dealing 2024

Sep 12, 2024

30826_dirs_2024-09-12_095b600e-da9b-41e2-b201-89fb297f8548.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2024-09-10

Reporting Person: Hunt Anthony (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-10 Common Stock M 10000 $33.87 Acquired 162031 Direct
2024-09-10 Common Stock S 1495 $143.77 Disposed 160536 Direct
2024-09-10 Common Stock S 9369 $144.88 Disposed 151167 Direct
2024-09-10 Common Stock S 10723 $145.95 Disposed 140444 Direct
2024-09-10 Common Stock S 604 $146.67 Disposed 139840 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-09-10 Stock Option (Right to Buy) $33.87 M 10000 Acquired 2028-02-29 Common Stock (10000) Direct

Footnotes

F1: Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on November 9, 2023.

F2: $143.77 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.44 to $144.28, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: $144.88 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.45 to $145.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: $145.95 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.49 to $146.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: $146.67 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.49 to $146.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6: This option is fully vested and exercisable.